- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02243072
Home-Based Interventions for Adolescents With Type 1 Diabetes (R34)
Translating Home-Based Interventions for Adolescents With Poorly Controlled TID
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The proposed study is a planning grant in which MST will be adapted for delivery by community health workers and will be conducted in collaboration with CHASS, a community agency providing health care to underserved residents of Detroit with diabetes. The new intervention, Fit Families (FF), will be tested in a pilot randomized controlled trial in order to evaluate FF feasibility, finalize outcome measures, estimate intervention effect sizes on health outcomes (i.e., youth adherence, glycemic control, quality of life) and determine potential cost savings associated with reduced hospital admissions. These steps will allow for finalization of intervention content and other trial parameters in preparation for a larger R18 dissemination trial.
The design for the proposed study is a randomized, controlled trial using a sample of 60 adolescents. Half will be randomly assigned to the treatment intervention, Fit Families plus standard medical care, and the other half will be assigned to standard medical care alone. Families who are randomized to FF receive intensive, home-based family therapy delivered by a community health worker (CHW) for approximately six months.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Michigan
-
Detroit, Michigan, Forenede Stater, 48201
- Children's Hospital of Michigan
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- a current hemoglobin A1c(HbA1c) of >9.0%
- an average HbA1c of >9.0% during the past year
- reside in the metro Detroit tri-county area
- diagnosed with Type 1 diabetes for at least one year
- aged 10-17
- patient of Children's Hospital of Michigan Diabetes Clinic
Exclusion Criteria:
- severe mental impairment/thought disorder
- Active suicidality
- Active homicidality
- Diabetes secondary to another comorbid medical condition and/or medical management differing substantially from that of most children with diabetes.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Enkelt gruppeopgave
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Fit Familes plus Standard Medical Care
Participants will receive the intervention Fit Families plus Standard Medical Care which is an adaptation of Multisystemic Therapy for Type 1 Diabetes delivered by Community Health Workers (CHWs) in addition to standard medical care.
|
Adolescents will receive the Fit Families plus Standard Medical Care which consists of twice weekly home-based, family psychotherapy from a CHW for 6 months
|
|
Ingen indgriben: Standard Medical Care
Standard medical care is provided at Children's Hospital of Michigan consistent with the standards for the care of children with T1D outlined by the American Diabetes Association.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Metabolic Control: Hemoglobin A1c (HbA1c)
Tidsramme: Change from Baseline at 7 months, Change from Baseline at 9 months
|
retrospective measure of blood glucose control, encompasses the previous 2-3 months
|
Change from Baseline at 7 months, Change from Baseline at 9 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
DKA admissions and emergency room (ER) Visits: hospital information systems data extraction, Service Utilization Questionnaire (SUQ)
Tidsramme: Change from Baseline at 7 months, Change from Baseline at 9 months
|
The number of patient visits to acute care settings represents a significant health care cost in this high-risk population.
|
Change from Baseline at 7 months, Change from Baseline at 9 months
|
|
Quality of life
Tidsramme: Change from Baseline at 7 months, Change from Baseline at 9 months
|
44 scale item designed to tap life satisfaction, diabetes impact and diabetes related worries in adolescents.
|
Change from Baseline at 7 months, Change from Baseline at 9 months
|
|
Regimen Adherence: Diabetes Management Scale (DMS), Glucose Meter Downloads
Tidsramme: Change from Baseline at 7 months, Change from Baseline at 9 months
|
The DMS assesses a broad range of management behaviors, such as insulin management, dietary management, blood glucose monitoring, symptom response, and parent assistance/supervision.
Glucose meters only assess blood glucose monitoring, but are empirically linked to metabolic control
|
Change from Baseline at 7 months, Change from Baseline at 9 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Deborah A Ellis, Ph.D, Wayne State University
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 1R34DK102091-01 (U.S. NIH-bevilling/kontrakt)
- R34DK102091 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Type 1 diabetes
-
COUR Pharmaceutical Development Company, Inc.RekrutteringType 1 diabetes | Type 1 diabetes mellitus | T1DM | T1D | Type 1-diabetes i ungdomsårene | Type 1-diabetes hos børn | Type 1-diabetespatienter | Type 1 diabetes melitis | T1DM - Type 1 Diabetes Mellitus | Type 1-diabetes (juvenil debut)Forenede Stater
-
Lund UniversityTilmelding efter invitationType 1 diabetes mellitus | Fase 2 Type 1-diabetes | Fase 1 type 1 diabetes | Trin 3 type 1 diabetesSverige
-
Oxford Brookes UniversityUniversity of OxfordAfsluttetFysisk aktivitet | Mental sundhed velvære 1 | Kognitiv funktion 1, Social | Akademisk opnåelse | KonditionstestDet Forenede Kongerige
-
Superior UniversityAktiv, ikke rekrutterendeType 2 Diabetes Mellitus 1Pakistan
-
Immunocore LtdIkke rekrutterer endnuType 1 diabetes | Diabetes type 1 | Type 1-diabetes (T1D)
-
Thomas Aagaard RasmussenAarhus University Hospital; The Alfred; Germans Trias i Pujol Hospital; Walter...Rekruttering
-
SanionaAfsluttet
-
Calliditas Therapeutics ABEurofins Optimed; York Bioanalytical SolutionAfsluttet
-
Calliditas Therapeutics ABAfsluttet
-
Penn State UniversityPenn State HealthIkke rekrutterer endnu
Kliniske forsøg med Fit Families plus Standard Medical Care
-
Wake Forest University Health SciencesNational Institutes of Health (NIH)RekrutteringPædiatrisk fedme | Vægttab | Forældre-barn relationer | Overvægtige unge | Familie og HusstandForenede Stater
-
Mansoura UniversityAfsluttetBenign prostatahyperplasiEgypten